Therapeutic Asset Ratings

146 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tas-102 Recurrent Ovarian Carcinoma	National Cancer Institute (NCI)	P2	B (59)
Tas-102 MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients	Shanghai EpimAb Biotherapeutics Co., Ltd.	P1/2	B (59)
Tas-102 Bladder Cancer	National Cancer Institute (NCI)	P2	B (58)
Tas-102 Dynamic Tumor Resistance	M.D. Anderson Cancer Center	P2	B (58)
Bcd-217 Melanoma (Skin)	Biocad	P3	B (57)
Karxt Psychosis	Bristol-Myers Squibb	P3	B (57)
Darzalex Faspro Non-small Cell Lung Cancer With STK11/LKB1 Mutation	NYU Langone Health	P2	B (57)
Tas-102 Advanced Sarcomatoid Renal Cell Carcinoma	M.D. Anderson Cancer Center	P2	B (57)
Tas-102 Kidney Carcinoma	National Cancer Institute (NCI)	P2	B (57)
Tas-102 Locally Advanced Papillary Renal Cell Carcinoma	M.D. Anderson Cancer Center	P2	B (57)
Bcd-217 Melanoma	Biocad	P3	B (56)
Tas-102 Colorectal Carcinoma	University of California, Irvine	P2	CCC (55)
Cagrisema Obesity	Novo Nordisk A/S	P3	CCC (54)
Cagrisema Type 2 Diabetes	Novo Nordisk A/S	P3	CCC (54)
Darzalex Faspro Multiple Myeloma	Shanghai Henlius Biotech	P3	CCC (54)
Liposomal Cytarabine-Daunorubicin Cpx-351 Acute Myeloid Leukemia	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.	P3	CCC (54)
Autologous Cd34+ Cells Transduced With Tns9.3.55 Beta Thalassemia Major	Daniel Bauer	P1/2	CCC (54)
Aphp-002 Obese With Comorbidities	Aphaia Pharma US LLC	P2	CCC (53)
Cald Hr-D Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D Adrenoleukodystrophy With Cerebral Involvement	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D Alpha-methylacyl-CoA Racmase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D D-Bifunctional Enzyme Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cald Hr-D Fucosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 26 to 50 of 146 assets

PreviousPage 2 of 6Next